Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of the Peripheral Nervous System : JPNS|May 30, 2020
Home monitoring of maintenance intravenous immunoglobulin therapy in patients with chronic inflammatory neuropathyPietro Emiliano Doneddu, Daniele Mandia, Francesco Gentile, et al.
Muscle & Nerve|July 22, 2008
A new single-nucleotide deletion of PMP22 in an HNPP family without recurrent palsiesMarco Luigetti, Amelia Conte, Francesca Madia, et al.
Journal of the Peripheral Nervous System : JPNS|April 11, 2024
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic reviewClaudia Cutellè, Alberto De Lorenzo, Pietro Emiliano Doneddu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 10, 2024
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapiesPietro Emiliano Doneddu, Dario Cocito, Raffaella Fazio, et al.
Journal of Translational Autoimmunity|September 22, 2025
Splicing-based biomarkers define a robust multigene classifier for relapsing-remitting multiple sclerosisFederica Airi, Valeria Rimoldi, Elvezia Maria Paraboschi, et al.
Multiple Sclerosis and Related Disorders|November 29, 2022
The circular RNA landscape in multiple sclerosis: Disease-specific associated variants and exon methylation shape circular RNA expression profileGiulia Cardamone, Elvezia Maria Paraboschi, Giulia Soldà, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 12, 2014
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosisClara Guaschino, Federica Esposito, Giuseppe Liberatore, et al.
Journal of Neuroimmunology|June 17, 2020
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathyGiuseppe Liberatore, Claudia Giannotta, Blesson Punnen Sajeev, et al.
Brain : a Journal of Neurology|December 10, 2024
Rituximab versus placebo for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized trialEduardo Nobile-Orazio, Dario Cocito, Fiore Manganelli, et al.
Pageof 3